Side view of Evangelia analyzing medical schematics at a light table, cool natural daylight, sharp focus, clinical slate and teal tones, 35mm lens.
Side view of Evangelia analyzing medical schematics at a light table, cool natural daylight, sharp focus, clinical slate and teal tones, 35mm lens.
View Case Studies
/ TRANSLATIONAL STRATEGY

Translating clinical science into architecture

Bridging the gap between complex deep-tech engineering and market-ready medical solutions. We combine rigorous academic precision with commercial execution to design viable, regulatory-ready clinical pathways.

Close-up of hands calibrating a complex biomedical hardware prototype in a clean modern laboratory, cool daylight, slate tones, 35mm lens.
Close-up of hands calibrating a complex biomedical hardware prototype in a clean modern laboratory, cool daylight, slate tones, 35mm lens.
THE METHODOLOGY

Rigorous clinical-to-market translation

Developing modern medical technologies requires more than raw engineering capability. It demands a deep understanding of complex physiological systems, strict regulatory pathways, and the commercial architecture necessary for venture-scale market scaling.

By aligning academic precision with strategic market de-risking, we ensure that breakthrough clinical research successfully navigates the translation pathway from lab to bedside, prioritizing patient outcomes and long-term regulatory compliance.

/ QUALIFICATIONS

Milestones in translation

Academic Rigor

Regulatory Mastery

Venture Scale

Rigorous academic foundations in Biomedical Engineering with specialized doctoral-level research focusing on complex physiological systems, computational modeling, and translational clinical science.

Structuring robust regulatory-ready roadmaps that satisfy strict FDA and CE-MDR requirements, ensuring that deep-tech healthcare investments are systemically de-risked at the earliest stages.

Partnering with healthcare venture funds, research institutions, and early-stage medtech startups to translate complex clinical assets into scalable, high-value commercial healthcare products.

Initiate Advisory

De-risk your clinical pipeline.

Advising medtech founders, healthcare venture funds, and research institutions globally. Let's discuss your clinical-to-market strategy.